Bluefin BioMedicine logo

Bluefin BioMedicine

Bluefin BioMedicine is a privately held company focused on the detection of novel cancer antigens and the development of next-generation effective antibody-based treatments for orphan cancer indications that will impact underserved patients.

Bluefin Biomedicine was established by Dr. Michael Comb is a successful scientist and entrepreneur who founded Cell Signaling Technology, a company dedicated to the creation of research and diagnostic antibodies essential for cancer research.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.bluefinbiomed.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
32 Tozer Road,MA,1915
Beverly
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/bluefin-biomedicine” connections=”true” suffix=””]

Bluefin BioMedicine uses its proprietary, cutting-edge protein detection methods to interrogate complex tumor specimens and discover differentially expressed cancer antigens that can be targeted with antibody therapies.